US Patent 9708371 | US Patents | Expiry | Expiration | Dates

U.S.A

LINACLOTIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9708371

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-08-16

Patent Use Code

U-1516

Delist Requested

Application Number

202811

Patent Use Description

METHOD OF TREATING CHRONIC IDIOPATHIC CONSTIPATION IN ADULT PATIENTS.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

LINACLOTIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9708371

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-08-16

Patent Use Code

U-1516

Delist Requested

Application Number

202811

Patent Use Description

METHOD OF TREATING CHRONIC IDIOPATHIC CONSTIPATION IN ADULT PATIENTS.

Product Number

3

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

LINACLOTIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9708371

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-08-16

Patent Use Code

U-1515

Delist Requested

Application Number

202811

Patent Use Description

METHOD OF TREATING IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULT PATIENTS.

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

LINACLOTIDE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9708371

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-08-16

Patent Use Code

U-1515

Delist Requested

Application Number

202811

Patent Use Description

METHOD OF TREATING IRRITABLE BOWEL SYNDROME WITH CONSTIPATION IN ADULT PATIENTS.

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

LINACLOTIDE